Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q3 2024 Earnings Call Transcript
Operator: Greetings, and welcome to Aurinia Pharmaceuticals Third Quarter 2024 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.
Aurinia Pharmaceuticals Inc. (AUPH)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Armistice Capital Steven Boyd | 8,200,000 | $60,106,000 | -27% | 0.96% |
| 2. | Tang Capital Management Kevin C. Tang | 7,229,500 | $52,992,235 | +161% | 3.78% |
| 3. | Rock Springs Capital Management Kris Jenner, Gordon Bussard, Graham Mcphail | 1,179,740 | $8,647,494 | 0.28% | |
| 4. | AQR Capital Management Cliff Asness | 568,318 | $4,165,771 | +182% | 0% |
| 5. | Citadel Investment Group Ken Griffin | 546,872 | $4,008,571 | -42% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.09 | 500,000 | 8,429,500 | 2024-12-09 | Filing | ||
| $9.01 | 400,000 | 7,929,500 | 2024-12-06 | Filing | ||
| $8.91 | 300,000 | 7,529,500 | 2024-12-05 | Filing | ||
| $8.91 | 20,000 | Director | 70,000 | 2023-03-02 | Filing | |
| $4.66 | 10,000 | Officer | 27,927 | 2022-11-21 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.43 | 4,557 | Director | 13,356 | 2024-11-11 | Filing | |
| $8.43 | 5,241 | Director | 12,672 | 2024-11-11 | Filing | |
| $5.31 | 18,249 | Officer | 456,338 | 2024-08-06 | Filing | |
| $5.74 | 520 | Director | 17,523 | 2024-05-21 | Filing | |
| $5.74 | 5,252 | Director | 28,141 | 2024-05-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,921,049 | $80,200,231 | 0% | |
| 2. | 3,969,834 | $35,688,808 | 2.37% | |
| 3. | 2,704,382 | $24,312,394 | 0% | |
| 4. | 2,352,125 | $21,145,604 | 0% | |
| 5. | 2,048,456 | $18,415,619 | 0% |
News See All
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q2 2024 Earnings Call Transcript
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q2 2024 Earnings Call Transcript August 1, 2024Aurinia Pharmaceuticals Inc. misses on earnings expectations.
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2024 Earnings Call Transcript
Aurinia Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.07464, expectations were $-0.17.
11 Oversold Biotech Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold biotech stocks to buy right now.
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2023 Earnings Call Transcript
Aurinia Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $-0.19 EPS, expectations were $-0.18.
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q3 2023 Earnings Call Transcript
Operator: Greetings. Welcome to Aurinia Pharmaceuticals Third Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
13 Stocks to Buy with Exponential Growth
Optimism was prevailing in the US stock market on October 11 as investors were hopeful that the Federal Reserve won’t take a hawkish stance for the rest of the year amid rising bond yields that are ...
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q2 2023 Earnings Call Transcript
Operator: Greetings. And welcome to Aurinia Pharmaceuticals Incorporated Second Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2023 Earnings Call Transcript
Operator: Greetings, and welcome to Aurinia Pharmaceuticals Inc. First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2022 Earnings Call Transcript
Operator: Greetings, and welcome to the Aurinia Pharmaceuticals Fourth Quarter and Full Year 2022 Results Conference Call. At this time all participants are in a listen-only mode.
Billionaire Hedge Funds
